Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 32 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 8399493

    Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

    Addex Pharmaceuticals S.A. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  2. US 8399449

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  3. US 8388963

    Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  4. US 8389557

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  5. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  6. US 8383647

    Quinoline derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  7. US 8383628

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  8. US 8372860

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  9. US 8367655

    Pyridoindolobenzox—and thiazepine derivatives and uses thereof

    DAYA DRUG DISCOVERIES, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  10. US 8367694

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  11. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  12. US 8361968

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  13. US 8362032

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  14. US 8357702

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted
  15. US 8354477

    Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted
  16. US 8350065

    5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same

    GRANDPHARMA (CHINA) CO., LTD. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  17. US 8349355

    Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

    Anika Therapeutics S.r.l. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  18. US 8343763

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  19. US 8344138

    Triazinedione derivatives as GABAB receptor modulators

    Addex Pharma, S.A. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  20. US 8338461

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  21. US 8338462

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  22. US 8338624

    Isoflavone derivatives and uses thereof

    Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  23. US 8334294

    4,8-diphenyl-polyazanaphthalene derivatives

    Almirall, S.A. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  24. US 8334259

    Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted